Fig. 2From: Delivering the precision oncology paradigm: reduced R&D costs and greater return on investment through a companion diagnostic informed precision oncology medicines approachEstimated research and development expenditures of oncology medicines. A Precision oncology medicines. Panel B Non-precision oncology medicines. R&D research and developmentBack to article page